Your biopharmaceutical company is developing new biological entities (NBE) and is thinking about launching or out-licensing a new biopharmaceutical product? Celonic is highly experienced in all aspects of this complex business sector. We know exactly what is required for drug development, biotechnological production and quality control: cell lines and processes that can be scaled up from the laboratory to the production scale, knowledge of GMP procedures, regulatory requirements and of approval and release procedures. We will help you implement strategies that will keep development and production costs low and project run times short. We are constantly striving for a working relationship based on appreciation and trust. We want you to be happy with the relationship you have with us.